Low-dose naltrexone in the treatment of fibromyalgia: A systematic review and narrative synthesis (Abstract)

Low-dose naltrexone in the treatment of fibromyalgia: A systematic review and narrative synthesis Aust J Gen Pract April 2023 https://www1.racgp.org.au/ajgp/2023/april/low-dose-naltrexone-in-the-treatment-of-fibromyalg Method: A systematic literature search was conducted using the key words ‘naltrexone’, ‘fibromyalgia’, ‘fibrositis’, ‘chronic pain’ and ‘neurogenic inflammation’. Results: Manual exclusion led to the identification of 21 papers, with only five prospective controlled trials […]

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia… (Abstract)

Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis Biomedicines As revised 23 March 2023 https://www.mdpi.com/2227-9059/11/4/1087 Current pharmacologic treatments may provide limited analgesia in fibromyalgia and other chronic pain disorders. Low-dose naltrexone (LDN) has emerged as a potential analgesic option that […]

Treating Long-COVID Brain Fog With ME/CFS Guidelines (Abstract)

Treating Long-COVID Brain Fog With ME/CFS Guidelines Medscape 27 March 2023 https://www.medscape.com/viewarticle/989887 Cognitive symptoms, commonly referred to as brain fog, are among the most common persistent or new symptoms after COVID-19. Cognitive symptoms are also often reported by patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). There are five things to know about using ME/CFS symptom […]

An Update on the Uses of Naltrexone in Clinical Practice (Abstract)

An Update on the Uses of Naltrexone in Clinical Practice Natural Medicine Journal 01 August 2022 https://www.naturalmedicinejournal.com/journal/an-update-on-the-uses-of-naltrexone-in-clinical-practice The principal purpose of this paper is to review various dosing options of naltrexone for use in clinical practice. Naltrexone can help treat a variety of conditions, including autoimmune diseases, neurodegenerative diseases, and acute or chronic pain, with […]

Low-dose naltrexone (LDN): consumption trend in Brazilian capitals… (in Portuguese) (Abstract)

[Low-dose naltrexone (LDN): consumption trend in Brazilian capitals and the Federal District, 2014-2020] [Article in Portuguese] Cien Saude Colet March 2023 https://pubmed.ncbi.nlm.nih.gov/36888876/ The scope of this paper is an ecological study to determine the consumption of low-dose naltrexone (LDN) in the 26 Brazilian capitals and the Federal District and monitor the trend between the years […]

Surmounting withdrawal to initiate fast treatment with naltrexone (SWIFT)… (Abstract)

Surmounting withdrawal to initiate fast treatment with naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study Contemp Clin Trials 15 March 2023 https://pubmed.ncbi.nlm.nih.gov/36931426/ Background: Extended-release injectable naltrexone (XR-NTX) is an effective treatment for opioid use disorder (OUD), but initiation remains a barrier to implementation. Standard practice requires a 10- to 15-day inpatient admission prior […]

Diagnosis and Management of a Hypersensitivity Reaction to Titanium-Containing Surgical Clips… (Abstract)

Diagnosis and Management of a Hypersensitivity Reaction to Titanium-Containing Surgical Clips: A Case Report Cureus 13 Feb 2023 https://pubmed.ncbi.nlm.nih.gov/36938272/ Although titanium allergies are not commonly diagnosed, they can present with a variety of conditions years after the implantation of titanium-containing medical devices. Furthermore, there are few options to effectively manage the long-term outcomes of these […]

The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia… (Abstract)

The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review J Pain Res 21 Mar 2023 https://pubmed.ncbi.nlm.nih.gov/36974308/ Fibromyalgia (FM) is a chronic pain sensitivity syndrome characterized by diffuse musculoskeletal pain and many other systemic manifestations. Low-dose naltrexone (LDN) has been increasingly used as an off-label treatment option in FM. However, current […]

Compounding for the Treatment of COVID-19 and Long COVID, Part 2… (Abstract)

Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment Int J Pharm Compd Mar-Apr 2023 https://pubmed.ncbi.nlm.nih.gov/37000135/ Described by some authors as a “black swan event . . . likened to the economic scene of World War Two,” the effects of coronavirus-disease-2019 (COVID-19) and attempted techniques for […]

Long COVID: major findings, mechanisms and recommendations (Abstract)

Long COVID: major findings, mechanisms and recommendations Nature reviews: microbiology 13 January 2023 https://www.nature.com/articles/s41579-022-00846-2 Long COVID is an often debilitating illness that occurs in at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. More than 200 symptoms have been identified with impacts on multiple organ systems. At least 65 million individuals worldwide […]